Research Publications

Abraham DJ, Black CM, Denton CP, Distler JHW, Domsic R, Feghali-Bostwick C, Gourh P, Hinchcliff M, Kolling F 4th, Kuwana M, Lafyatis R, Landegren U, Mahoney JM, Martin J, Matucci-Cerinic M, McMahan ZH, Mora AL, Mouthon L, Rabinovitch M, Rojas M, Rubin K, Trojanowska M, Varga J, Whitfield ML, Gabrielli A, Krieg T. An international perspective on the future of systemic sclerosis research Nat Rev Rheumatol. 2025 Mar;21(3):174-187. doi: 10.1038/s41584-024-01217-2. Epub 2025 Feb 14.PMID: 39953141 

Auth J, Müller F, Völkl S, Bayerl N, Distler JHW, Tur C, Raimondo MG, Chenguiti Fakhouri S, Atzinger A, Coppers B, Eckstein M, Liphardt AM, Bäuerle T, Tascilar K, Aigner M, Kretschmann S, Wirsching A, Taubmann J, Hagen M, Györfi AH, Kharboutli S, Krickau T, Dees C, Spörl S, Rothe T, Harrer T, Bozec A, Grieshaber-Bouyer R, Fuchs F, Kuwert T, Berking C, Horch RE, Uder M, Mackensen A, Schett G, Bergmann C. CD19-targeting CAR T-cell therapy in patients with diffuse systemic sclerosis: a case series Lancet Rheumatol. 2025 Feb;7(2):e83-e93. doi: 10.1016/S2665-9913(24)00282-0. Epub 2024 Nov 11.PMID: 39542003 

Mougiakakos D, Sengupta R, Gold R, Schroers R, Haghikia A, Lorente M, Pendleton M, Register A, Heesen C, Kröger N, Schett G, Mackensen A, Podoll A, Gutman J, Furie R, Bayer R, Distler JHW, Dietrich S, Krönke G, Bullinger L, Walker K. Successful generation of fully human, second generation, anti-CD19 CAR T cells for clinical use in patients with diverse autoimmune disorders. Cytotherapy. 2025 Feb;27(2):236-246. doi: 10.1016/j.jcyt.2024.09.008. Epub 2024 Oct 5.PMID: 39530971 

Deicher FS, Exner T, Claus M, Yousefian S, Rodon L, Leonhardt SE, Distler JHW, Watzl C, Lorenz HM, Haas S, Hübschmann D, Merkt W. Compartment-Specific NK Cell Phenotypes Reveal Distinct Maturation and Activation States in Inflammatory Arthritis. J Innate Immun. 2025;17(1):522-538. doi: 10.1159/000548548. Epub 2025 Oct 31.PMID: 41363790